Article

AMO names new president, Randy Meier

Santa Ana, CA-Richard "Randy" A. Meier has been named president of Advanced Medical Optics Inc. (AMO), effective Nov. 19

Santa Ana, CA-Richard “Randy” A. Meier has been named president of Advanced Medical Optics Inc. (AMO), effective Nov. 19. He retains his existing chief operating officer (COO) title and responsibilities, which include leadership of the company’s eye care and cataract/implant businesses, global customer services, and manufacturing operations.

James V. Mazzo, previous holder of the title of president, remains the company’s chairman and chief executive officer.

“Randy has assumed increasingly broad leadership roles since our spin-off [from Allergan] in 2002 and, over that time, has played an integral role in the growth and development of our company,” said Mazzo. “I am confident in his ability to serve as president, continuing to work closely with me and the AMO leadership team to execute our strategy and deliver on our operational and financial goals.”

Meier joined AMO in 2002 as corporate vice president and chief financial officer (CFO). Subsequently, he held various positions, including executive vice president, operations, and president, eye-care business. In February, he was named COO and CFO, a position he held until October, when Michael Lambert joined the company as CFO.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.